CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000DJ3FF70

Delayed Deutsche Boerse AG 01:04:28 28/05/2024 am IST
59.14 EUR +0.41% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+5.95%
1 month+10.85%
Date Price Change
27/24/27 59.14 +0.41%
24/24/24 58.9 +0.53%
23/24/23 58.59 -0.19%
22/24/22 58.7 -0.31%
21/24/21 58.88 -0.25%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 01:04 am IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DJ3FF7
ISINDE000DJ3FF70
Date issued 22/06/2023
Strike 60
Maturity 21/06/2024 (25 Days)
Parity 1 : 1
Emission price 50.46
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 59.26
Lowest since issue 32.8

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.77 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.77%
Consensus